Use twice daily, in the morning and evening, for best results
The blend sits at the front edge of metabolic research, which is exactly why the marketing runs ahead of the evidence
aligns with phase 2 obesity trial readouts
March 8, 2026: More Deaths, Adverse Events Reported About Patients Taking Mounjaro, Other GLP-1s The U.K.s Medicines and Healthcare products Regulatory Authority received 1,296 reports of pancreatitis involving patients taking GLP-1 drugs (like Mounjaro) between 2007 and 2025
To view or add a comment, sign in "Specifically, at week 12 of the study, Baxfendy 2-mg helped reduce patients blood pressure on average by nearly 10 mmHg when adjusted for placebo
Furthermore, -pinene activated the transient receptor potential ankyrin 1 (TRPA1) channel, amplifying its vascular effects and suggesting its potential to improve cardiovascular health through increased NO release (Jin et al., 2023)